Our data suggest that PTE remodels the tumor microenvironment (TME) by activating STING-mediated signaling, leading to increased chemokine production (e.g., CXCL10, CCL5) and enhanced CD8+ T-cell recruitment and function. The gene discussed is CXCL10; the disease is neoplasm.